A 2015 review during the Journal of Being overweight & Metabolic Syndrome addresses frequent adverse occasions and serious Unwanted effects of anti-being overweight medications, which include phentermine/topiramate that have to have monitoring, for example metabolic acidosis, urolithiasis, acute angle closure glaucoma, and teratogenic outcomes ( ei